Presentations - HUMACYTE

PRESENTATIONS

June 10, 2021

Humacyte to Participate in Fireside Chat at Cowen 6th Annual FutureHealth Conference

June 08, 2021

Humacyte Presents In Vivo Data on Biovascular Pancreas Transplantation for Type 1 Diabetes Treatment

June 04, 2021

Humacyte to Provide Investor Update
on June 7

May 21, 2021

Humacyte Presents Advances in Whole-Lung Engineering

March 5, 2021

Humacyte to Present Long-Term Follow-Up Data from Phase 2 Vascular Access Trial at Charing Cross (CX) International Symposium 2021

February 17, 2021

Humacyte, a Transformative Biotechnology Platform Company Capable of Manufacturing Universally Implantable Bioengineered Human Tissue at Commercial Scale, Going Public via Merger with Alpha Healthcare Acquisition Corp.

We are committed to bringing first-in-class regenerative medicine products to the marketplace that will improve and save the lives of patients worldwide and transform the practice of medicine.

PRIVACY POLICY

EXPANDED ACCESS POLICY

CONFLICT OF INTEREST

TRANSPARENCY IN COVERAGE

(919) 313-9633

™ Indicates a trademark of Humacyte Global, Inc.
© 2023 Humacyte Global, Inc. All Rights Reserved. | Sitemap

™ Indicates a trademark of Humacyte Global, Inc.
© 2023 Humacyte Global, Inc. All Rights Reserved.